Skip to main content

Advertisement

SpringerLink
Log in

Association of baseline severity of lower urinary tract symptoms with the success conservative therapy for urinary incontinence in women

  • Original Article
  • Published:
International Urogynecology Journal Aims and scope Submit manuscript

Abstract

Introduction and hypothesis

To identify the association between the symptom severity and outcome of conservative management for OAB, SUI and MUI. Conservative treatments are recommended for overactive bladder (OAB), stress urinary incontinence (SUI) and mixed incontinence (MUI). It is unclear whether disease severity affects treatment outcome.

Methods

Patients receiving conservative management were reviewed. Disease-specific questionnaires (OAB-q SF, ICIQ-UI SF) and bladder diaries recorded baseline symptoms. Success was defined by Patient Global Impression of Improvement questionnaire (PGI-I) response of “very much better” or “much better”. Non-parametric statistical tests and logistic regression were used.

Results

In 50 OAB patients success was associated with lower symptom severity [30 (0–80) vs. 80 (23–100), p = 0.0001], fewer urgency episodes [4 (0–12) vs. 6 (0–11), p = 0.032] and lower ICIQ-UI SF [5.5 (0–20) vs. 15 (0–21), p = 0.002], but higher QoL [67 (20–101) vs. 24 (6–58), p = 0.0001]. In 50 MUI patients, variables were fewer urgency episodes [3 (0–10) vs. 6 (0–16), p = 0.004] and lower ICIQ-UI [11 (1–18) vs. 15 (5–21), p = 0.03]. In 40 SUI patients, variables were fewer incontinence episodes [1 (0–4) vs. 2 (0–5), p = 0.05] and lower ICIQ-UI [11 (6–16) vs. 13.5 (11–19), p = 0.003]. Multiple regression confirmed OAB-q QoL [odds ratio (OR) 1.10 (95% confidence intervals 1.04, 1.1)] for OAB, urgency episodes [OR 0.74 (0.56, 0.98)] and ICIQ-UI [OR 0.83 (0.71, 0.98] for MUI and ICIQ-UI [OR 0.57 (0.40, 0.83)] for SUI.

Conclusions

Milder baseline disease severity was associated with successful outcome. There is potential for triage at initial assessment to second-line interventions for women unlikely to achieve success.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Irwin DE, Kopp ZS, Agatep B, Milsom I, Abrams P. Worldwide prevalence estimates of lower urinary tract symptoms, overactive bladder, urinary incontinence and bladder outlet obstruction. BJU Int. 2011;108(7):1132–8.

    Article  PubMed  Google Scholar 

  2. Milsom I, Coyne KS, Nicholson S, Kvasz M, Chen CI, Wein AJ. Global prevalence and economic burden of urgency urinary incontinence: a systematic review. Eur Urol. 2014;65(1):79–95.

    Article  PubMed  Google Scholar 

  3. Abrams P, Cardozo L, Fall M, Griffiths D, Rosier P, Ulmsten U, et al. The standardisation of terminology in lower urinary tract function: report from the standardisation sub-committee of the International Continence Society. Urology. 2003;61:37–49.

    Article  PubMed  Google Scholar 

  4. Haylen BT, de Ridder D, Freeman RM, Swift SE, Berghmans B, Lee J, et al. An International Urogynecological Association (IUGA)/International Continence Society (ICS) joint report on the terminology for female pelvic floor dysfunction. Neurourol Urodyn. 2010;29:4–20.

    PubMed  Google Scholar 

  5. Practice Bulletin no. 155: Urinary incontinence in women. Obstetrics and Gynecology. 2015;126(5):e66–e81.

  6. Goldman HB, Wyndaele JJ, Kaplan SA, Wang JT. Defining response and non-response to treatment in patients with overactive bladder: a systematic review. Curr Med Res Opin. 2014;30(3):509–26.

    Article  CAS  PubMed  Google Scholar 

  7. Chapple CR, Kelleher CJ, Evans CJ, Kopp Z, Siddiqui E, Johnson N, et al. A narrative review of patient reported outcomes in overactive bladder: what is the way of the future? Eur Urol. 2016;70:799–805.

    Article  PubMed  Google Scholar 

  8. Burgio KL, Goode PS, Locher JL, Richter HE, Roth DL, Wright KC, et al. Predictors of outcome in the behavioural treatment of urinary incontinence in women. Obstet Gynecol. 2003;102:940–7.

    PubMed  Google Scholar 

  9. Cammu H, van Nylen M. Pelvic floor exercises: 5 years later. Urology. 1995;45:113–8.

    Article  CAS  PubMed  Google Scholar 

  10. Burgio KL, Whitehead WE, Engel BT. Urinary incontinence in elderly: bladder sphincter biofeedback and toileting skills training. Ann Intern Med. 1985;104:507–15.

    Article  Google Scholar 

  11. Owen RK, Abrams KR, Mayne C, Slack M, Tincello DG. Patient factors associated with Onabotulinum toxin A treatment outcome in women with detrusor overactivity. Neurourol Urodyn. 2017;36:426–31.

    Article  CAS  PubMed  Google Scholar 

  12. Schaffer J, Nager CW, Xiang F, Borello-France D, Bradley CS, Wu JM, et al. Predictors of success and satisfaction of non-surgical therapy for stress urinary incontinence. Obstet Gynecol. 2013;120(1):91–7.

    Article  Google Scholar 

  13. Ostaszkiewicz J, Chestney T, Roe B. Habit retraining for the management of urinary incontinence in adults. Cochrane Database Syst Rev. 2004;(2):CD002801.

  14. Wallace SA, Roe B, Williams K, Palmer M. Bladder training for urinary incontinence in adults. Cochrane Database Syst Rev. 2004;(1):CD001308.

  15. Dumoulin C, Hay-Smith EJC, Mac Habée-Séguin G. Pelvic floor muscle training versus no treatment, or inactive control treatments, for urinary incontinence in women. Cochrane Database Syst Rev. 2014;(5):CD005654.

  16. Jackson S, Donovan S, Brookes S, Eckford S, Swithinbank L, Abrams P. The Bristol lower urinary tract symptoms questionnaire: development and psychometric testing. BJU. 1996;77:805–12.

    Article  CAS  PubMed  Google Scholar 

  17. Avery K, Donovan J, Peters TJ, Shaw C, Gotoh M, Abrams P. ICIQ: a brief and robust measure for evaluating the symptoms and impact of urinary incontinence. Neurourol Urodyn. 2004;23(4):322–30.

    Article  PubMed  Google Scholar 

  18. Laycock J. Clinical evaluation of the pelvic floor. In: Schussler B, Laycock J, Norton P, Stanton SL, editors. Pelvic floor re-education. London: Springer-Verlag; 1994. p. 42–8.

    Google Scholar 

  19. Srikrishna S, Robinson D, Cardozo L. Validation of the patient global impression of improvement (PGI-I) for urogenital prolapse. Int Urogynecol J. 2010;21(5):523–8.

    Article  PubMed  Google Scholar 

  20. Hendriks EJ, Kessels AG, de Vet HC, Bernards AT, de Bie RA. Prognostic indicators of poor short-term outcome of physiotherapy intervention in women with stress urinary incontinence. Neurourol Urodyn. 2010;29:336–43.

    PubMed  Google Scholar 

  21. Ghei M, Malone-Lee J. Using the circumstances of symptom experience to assess the severity of urgency in the OAB. J Urol. 2005;171:972–6.

    Article  Google Scholar 

  22. Chapple C, Khullar V, Nitti VW, Frankel J, Herschorn S, Kaper M, et al. Efficacy of the beta3-adrenoreceptor agonist mirabegron for the treatment of overactive bladder by severity of incontinence at baseline: a post-hoc analysis of pooled data from three randomised phase 3 trials. Eur Urol. 2015;67:11–4.

    Article  CAS  PubMed  Google Scholar 

  23. Hsiao SM, Lin HH, Kuo HC. Factors associated with a better therapeutic effect of solifenacin in patients with overactive bladder syndrome. Neurourol Urodyn. 2014;33(3):331–4.

    Article  CAS  PubMed  Google Scholar 

  24. Serati M, Braga A, Siesto G, et al. Risk factors for the failure of antimuscarinic treatment with solifenacin in women with overactive bladder. Urology. 2013;82:1044–8.

    Article  PubMed  Google Scholar 

  25. Labrie J, Lagro-Jassen ALM, Fischer K, et al. Predicting who will undergo surgery after physiotherapy for female stress urinary incontinence. Int Urogynecol J. 2015;26:329–34.

    Article  CAS  PubMed  Google Scholar 

  26. Hendricks EJM, Kessels AGH, de Vet HCW, et al. Prognostic indicators of poor short-term outcome of physiotherapy intervention in women with stress urinary incontinence. Neurourol Urodyn. 2008;27(5):379–87.

    Article  Google Scholar 

  27. Schaffer J, Nager CW, Xiang F, et al. Predictors of success and satisfaction of non-surgical therapy for stress urinary incontinence. Obstet Gynecol. 2012;120(1):91–7.

    Article  PubMed  PubMed Central  Google Scholar 

  28. Klovning A, Avery K, Sandvik H, Hunskaar S. Comparison of two questionnaires for assessing the severity of urinary incontinence: the ICIQ-UI SF versus the incontinence severity index. Neurourol Urodyn. 2009;28(5):411–5.

    Article  PubMed  Google Scholar 

  29. Bo K, Larsen S. Pelvic floor muscle exercise for the treatment of female stress urinary incontinence: classification and characterisation of responders. Neurourol Urodyn. 1992;11:497–507.

    Article  Google Scholar 

  30. Neumann PB, Grimmer KA, Deenadayalan Y. Pelvic floor muscle training and adjunctive therapies for the treatment of stress urinary incontinence in women: a systematic review. BMC Womens Health. 2006;6:11.

    Article  PubMed  PubMed Central  Google Scholar 

  31. Knight S, Laycock J, Naylor D. Evaluation of neuromuscular electrical stimulation in the treatment of genuine stress incontinence. Physiotherapy. 1998;84(2):61–71.

    Article  Google Scholar 

  32. Turkan A, Inci Y, Fazli D. The short-term effects of physical therapy in different intensities of urodynamic stress incontinence. Gynecol Obstet Investig. 2005;59:43–8.

    Article  Google Scholar 

  33. Dumoulin C, Desmeule F, Hagen S, Masse BR, Mayrand M-H, Morin M, et al. Development and validation of a clinical prediction rule to guide and improve the treatment of female stress urinary incontinence. http://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=344799&lang=en. Accessed 13 Apr 2018.

Download references

Author information

Authors and Affiliations

  1. Urogynaecology Department, University Hospitals of Leicester, NHS Trust, Leicester, UK

    Aneta Obloza, Roderick Teo, Emily Marriott, Gillian Parker & Douglas Tincello

  2. Urogynaecology Department, Leicester General Hospital, Gwendolen Road, Leicester, LE4 5PW, UK

    Aneta Obloza

  3. University of Leicester, Leicester, UK

    Douglas Tincello

Authors
  1. Aneta Obloza
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Roderick Teo
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Emily Marriott
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Gillian Parker
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Douglas Tincello
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Aneta Obloza.

Ethics declarations

This work took place at the Leicester General Hospital NHS Trust, UK.

No ethical approval was required for this work.

Conflicts of interest

None.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Obloza, A., Teo, R., Marriott, E. et al. Association of baseline severity of lower urinary tract symptoms with the success conservative therapy for urinary incontinence in women. Int Urogynecol J 30, 705–710 (2019). https://doi.org/10.1007/s00192-018-3778-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00192-018-3778-0

Keywords

Search

Navigation